Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2009
05/06/2009CN101422454A Omega-3 polyunsaturated fatty acid tanshinone IIA sub-microemulsion and preparation method thereof
05/06/2009CN101422441A Nimesulide sustained-release tablet and preparation method thereof
05/06/2009CN101422271A Kudzu root nutrient effervescent tablets and manufacture technique thereof
05/06/2009CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase
05/06/2009CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin
05/06/2009CN100484560C Sarcandra powder injection and preparing method thereof
05/06/2009CN100484559C Chinese medicine preparation for treating acute and chronic appendicitis
05/06/2009CN100484532C Chinese medicine extract, its production and use in pharmacy
05/06/2009CN100484515C Guacetisal dry-mixing suspending agents and method of preparing the same
05/06/2009CN100484514C Injection medication of emu oil for antiinflammation and ease pain, and preparation method
05/06/2009CN100484417C Health care bamboo salt and its preparing method
05/05/2009US7528169 drugs separated from fermentation cultures of filamentous fungi, having angiogenesis inhibitory activity in a low oxygen condition
05/05/2009US7528164 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent
05/05/2009US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels
05/05/2009US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis
05/05/2009US7528151 Heterocyclic urea derivatives for the treatment of pain
05/05/2009US7528148 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors
05/05/2009US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors
05/05/2009US7528137 Compounds, compositions, and methods
05/05/2009US7528124 1,3-dihydro-2H-indol-2-one derivative
05/05/2009US7527790 Genetic engineered protein; screening, controlling gene expression
05/05/2009CA2537402C Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
05/05/2009CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors
05/05/2009CA2407854C Occlusive transdermal therapeutic system with a non-occlusive backing layer
05/05/2009CA2403352C Use of comt inhibitors as analgesics
05/05/2009CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy
05/05/2009CA2309818C Buffered drug formulations for transdermal electrotransport delivery
05/05/2009CA2234980C Cyclopeptide derivatives
05/05/2009CA2204747C New azo derivatives of 5-aminosalicylic acid
05/05/2009CA2146647C Treatment of autoimmune and inflammatory disorders
04/2009
04/30/2009WO2009055749A1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain
04/30/2009WO2009055357A1 Diazepane compounds which modulate the cb2 receptor
04/30/2009WO2009055350A1 Methods of treating chronic neurogenic inflammation using modified clostridial toxins
04/30/2009WO2009054970A1 Mesylate salt of an ikk inhibitor
04/30/2009WO2009053763A1 New non-peptide derivatives as bradykinin b1 antagonists
04/30/2009WO2009053459A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
04/30/2009WO2009053268A1 Novel phenyl-substituted piperazino-dihydrothienopyrimidines
04/30/2009WO2009052972A2 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels
04/30/2009WO2009052569A1 A method and medicament for pain management
04/30/2009WO2009027077A8 5-arylalkylidene-2-arylalkyl-thiazol-4-one derivatives as inhibitors of 5-lipoxygenase and uses thereof
04/30/2009WO2009011871A3 Thiadiazole modulators of pkb
04/30/2009WO2008140421A3 Heterocycloalkyl substituted pyrimidine derivatives
04/30/2009WO2008140420A3 Pyrimidine derivatives
04/30/2009WO2008140419A3 Pyridyl substituted pyrimidine derivatives
04/30/2009WO2008138889A3 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
04/30/2009WO2008109498A4 Nucleic acid compounds for inhibiting hdac gene expression and uses thereof
04/30/2009WO2008046598A8 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR
04/30/2009WO2005102389A9 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists
04/30/2009WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling
04/30/2009US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis
04/30/2009US20090111865 Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof
04/30/2009US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5
04/30/2009US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5
04/30/2009US20090111825 Thiophene 1,2,4-triazole derivatives as modulators of mglur5
04/30/2009US20090111813 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
04/30/2009US20090111811 1,2,4-triazole carboxylic acid derivatives as modulators of mglur5
04/30/2009US20090111806 Azaquinolone based compounds exhibiting prolyl hydroxylase Inhibitory activity, compositions, and uses thereof
04/30/2009US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
04/30/2009US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase
04/30/2009US20090110755 Compositions and Methods for Preventing Migraines
04/30/2009CA2711824A1 A method and medicament for pain management
04/30/2009CA2703754A1 Compositions and methods for treating inflammation
04/30/2009CA2703364A1 Methods of treating chronic neurogenic inflammation using modified clostridial toxins
04/30/2009CA2703290A1 New non-peptide derivatives as bradykinin b1 antagonists
04/30/2009CA2702976A1 2-aminooxazole derivatives as trpv1 antagonists useful for treating pain
04/30/2009CA2702772A1 Diazepane compounds which modulate the cb2 receptor
04/30/2009CA2702510A1 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels
04/30/2009CA2702447A1 New phenyl-substituted piperazino-dihydrothienopyrimidines
04/30/2009CA2700915A1 Cyclohexeneamide derivatives and their use as trpv1 antagonist
04/29/2009EP2053061A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
04/29/2009EP2053042A1 Pyridine compounds for the treatment of prostaglandin mediated diseases
04/29/2009EP2053039A1 Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof
04/29/2009EP2053038A1 Aminoalcohol derivative and immunosuppressant containing the same as an active ingredient
04/29/2009EP2052725A2 Use of lanthanum compounds for the treatment of bone diseases
04/29/2009EP2052724A1 Use of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC6 and TRPC7 ion channel
04/29/2009EP2052714A1 Topical gel delivery systems for treating skin disorders
04/29/2009EP2051967A1 Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
04/29/2009EP2051710A2 Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
04/29/2009EP1784177B1 Formulation for l-tryptophane comprising carbidopa/benserazide
04/29/2009EP1771421B1 N-hydroxyamide derivatives and use thereof
04/29/2009EP1765775B1 Indoles useful in the treatment of inflammation
04/29/2009EP1727555B1 Production of hop extracts having oestrogenic and antiproliferative bioactivity
04/29/2009EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
04/29/2009EP1485347B1 Hif hydroxylase inhibitors for use in the treatment of anaemia
04/29/2009EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists
04/29/2009EP1372685B1 Use of extracts of the plant litchi chinensis sonn.
04/29/2009EP1345910B1 Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
04/29/2009EP1304992B1 Topical gel delivery systems for treating skin disorders
04/29/2009EP1296652B1 Topical pharmaceutical formulations and methods of treatment
04/29/2009EP1218509B1 Fibroblast growth factor-like polypeptides
04/29/2009EP1066286B1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
04/29/2009CN101421288A Novel amphiphilic derivatives of alpha-C-phenyl-N-tert-butylnitrone
04/29/2009CN101421271A Purine derivatives as adenosine receptor activator
04/29/2009CN101421247A Novel imidazole derivatives, preparation and user thereof as medicine
04/29/2009CN101421240A Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
04/29/2009CN101420982A Dry direct compression fast disintegrating tablet
04/29/2009CN101420973A Pharmaceutical compositions comprising SODs and prolamine based peptide fragments
04/29/2009CN101420959A Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine A2A receptor agonists
04/29/2009CN101418032A Method for synthesizing deflazacort
04/29/2009CN101417912A Method for preparing becort acetate